Previous close | 35.00 |
Open | 35.00 |
Bid | 49.30 |
Ask | 50.65 |
Strike | 105.00 |
Expiry date | 2025-03-21 |
Day's range | 23.32 - 35.00 |
Contract range | N/A |
Volume | |
Open interest | 2 |
The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.
Moderna stock is on the rise again as investors focus on the potential need for a bird flu vaccine. Is MRNA stock a buy right now?
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.